Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis.

Kroksveen, Ann C; Jaffe, Jacob D; Aasebø, Elise; Barsnes, Harald; Bjørlykke, Yngvild; Franciotta, Diego; Keshishian, Hasmik; Myhr, Kjell-Morten; Opsahl, Jill A; van Pesch, Vincent; Teunissen, Charlotte E; Torkildsen, Øivind; Ulvik, Rune J; Vethe, Heidrun; Carr, Steven A; Berven, Frode S.
Proteomics; 15(19): 3361-9, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26152395